INTRODUCTION
Pharmacological copper (Cu) is routinely included in pig diets to improve pig growth and the most efficacious level has been reported to be 250 mg/kg in nursery pigs (Cromwell et al., 1989) . However, there is an increasing environmental concern with excessive excreted Cu in feces (Kornegay and Harper, 1997) . As a result, there is more pressure to reduce dietary Cu without compromising performance. The Commission of the European Communities (Byrne, 2003) regulates maximum allowed total Cu in feed with 170 mg/kg in piglets up to 12 wk of age and 25 mg/kg in all other pigs. A recent meta-analysis by Jongbloed et al. (2011) . Diets were medicated with antibiotics and supplemented with 3,000 mg/kg Zn as ZnO during phases I and/or II. Treatments included a basal diet without added Cu or according to the NRC (1998) and supplemental levels of Cu (50 to 250 mg Cu/kg diet) from either Cu(HMTBa) 2 or CuSO 4 ; HMTBa was supplemented to make diets isomethionine. Treatments from each trial included 6 or 9 replicate pens/treatment with 22 to 25 piglets/pen. Mixed model analysis was conducted in which trial was considered a random effect, Cu level was considered a continuous fixed effect, and Cu source was a fixed effect. The basal diet within trial and statistical tests of the intercept between sources were not different, resulting in fitting a common intercept mixed model to the overall responses across phases. Cumulative ADG and ADFI quadratically responded (P < 0.05) with increasing Cu supplementation; predicted optimal ADG and ADFI occurred at 174 and 119 mg/kg, respectively. Increasing Cu supplementation linearly improved G:F (P = 0.054). No differences between sources were observed in ADG or ADFI. Numerically, pigs fed Cu(HMTBa) 2 had higher ADG and lower ADFI compared to pigs fed CuSO 4 , resulting in better G:F for pigs supplemented with Cu(HMTBa) 2 compared to pigs supplemented with CuSO 4 (P < 0.01). The linear slope for increasing Cu supplementation on G:F was 2.1-fold higher for Cu(HMTBa) 2 than that of CuSO 4, with larger differences occurring in Phase II. In conclusion, Cu supplementation in nursery diets resulted in improved performance and Cu(HMTBa) 2 is more effective than CuSO 4 in improving feed efficiency .
Cu-Lys complex, and Cu(2-hydroxy-4-(methylthio) butanoic acid [HMTBa] ) 2 have been shown to be efficacious forms (Cromwell et al., 1989 (Cromwell et al., , 1998 Coffey et al., 1994; Richards et al., 2010) . Although organic mineral sources (chelates, complexes, or proteinates) have been proposed to be more bioavailable than inorganic sources, the literature provides inconsistent bioavailability among organic source and variability across studies (Baker and Ammerman, 1995; Cao et al., 2000 Cao et al., , 2002 Bikker et al., 2012) . Copper (2-hydroxy-4-(methylthio)butanoic acid) 2 (MINTREX; Novus International Inc., St. Charles, MO) is a chelate of 1 Cu with 2 HMTBa, providing available methionine equivalent and highly available Cu for animals (Zhao et al., 2009 Richards et al., 2010; Liu et al., 2013) . A correlation between the availability of Cu and the growth effect of Cu has been observed (Bowland et al., 1961; Cromwell et al., 1989) ; therefore, gain, feed intake, and feed efficiency differences between Cu(HMTBa) 2 and CuSO 4 could result in different dose-response curves.
To evaluate this hypothesis, a multitrial analysis was conducted to evaluate the effect of dose responses of Cu from either Cu(HMTBa) 2 or CuSO 4 on growth performance.
MATeRIALS AND MeTHODS

General
A total of 6 nursery trials were conducted from 2007 to 2012 at the University of Missouri (Columbia, MO) commercial research facility included in this multitrial analysis. All animal procedures were approved by the University of Missouri Animal Care and Use Committee. Analyzing the performance response to supplemental Cu across these 6 trials provides an advantage over analyzing the performance response in each of the individual trials in that a greater level of replication (pens and pigs) could be achieved and more levels of Cu could be tested than were in any individual trial. The descriptions of those trials are listed in Table 1 and calculated nutrient values are listed in Table 2 .
Animal, Diets, and Experimental Design
Weanling pigs (half barrows and half gilts; TR-4 × PIC C-22; PIC, Hendersonville, TN) with initial BW at 5.75 ± 0.41 kg at 21 ± 3 d of age were used in all 6 trials. Pigs were blocked on the basis of sex and initial BW and randomly assigned to dietary treatments. Each treatment consisted of 6 or 9 replicate pens, each with 22 to 25 piglets/pen. Pigs were allowed ad libitum access to feed and water during the entire experimental period. Pigs and feeder were weighed at trial initiation and at the end of each phase. (Table 3) ; since Cu(HMTBa) 2 contains a source of methionine, MHA feed supplement (containing 84% methionine activity; Novus International Inc.) was supplemented in treatment diets to make all diets isomethionine. The same basal diet was considered for both CuSO 4 and Cu(HMTBa) 2 in the regression statistical analysis.
Statistical Analysis
Data Collection and Calculation. All treatment least square means of each trial were obtained from trials summary reports and served as the data for regression analysis and source comparison. The results of the statistical analysis included the individual phase and the cumulative analysis for ADG, ADFI, and G:F. The cumulative ADG and ADFI of each trial were calculated from total BW gain or total feed intake divided by total trial days (42 d). The cumulative G:F of each treatment was computed by the ratio of cumulative ADG to cumulative ADFI. The cumulative added Cu was calculated from the total Cu intake divided by the total feed intake for each trial. Supplemental Table 1 lists trial data for the regression analysis.
Statistical Model. Data were analyzed by the following model based on the methodology described by St. Pierre (2001): 
In this multitrial analysis, trial was considered a random effect, Cu level was considered a continuous fixed effect, and Cu source was considered as a fixed effect. In addition, Cu source was included in this above model for testing the interaction of Cu level by × different source of Cu (St. Pierre, 2001) .
The interaction of level × source produces a test of the homogeneity of slopes across the source effects; the significance of this interaction indicates that individual fixed slopes should be fitted for each source of Cu; that is, 2 sources of Cu have distinct response curve. Lack of significance would indicate homogeneity of slopes; that is, 2 sources of Cu have the same response curve. Additionally, a quadratic extension of this model was evaluated.
Graph Presentation. It is common to present regression results in the form of a y versus x graph as presented in Fig. 1, 2 , and 3, where the regression line is shown in conjunction with the observation. As described by St. Pierre (2001) , the mixed model regression cannot be graphed this simplistically. This is because the observations come from a multidimensional space (observations from 6 trials in this data set). When observations are collapsed from the multidimensional space into a 2-dimensional space, it is important to correct or adjust the observations for the lost dimensions or else the regression will appear biased. To do this, adjusted y values were calculated to be used in an x-y graphic.
The y predicted values are simply the y values on the regression line to which each residual is added to its corresponding y predicted value to generate adjusted y values.
Basal diet within trial and statistical tests of the intercept between sources were not different (P > 0.50), resulting in fitting a common intercept mixed model to the overall responses across phases.
For ease of interpretation, the regression coefficients associated with each source will be reported, although the analysis was conducted as the deviation from the overall Cu response as detailed in the model.
For the entire analysis, P ≤ 0.05 was considered statistically significant and 0.05 < P < 0.10 was considered a trend. The cumulative optimal Cu dose response from combined both source in ADG is 174 mg/kg, the cumulative optimal Cu dose response from CuSO4 is 150 mg/kg, and the cumulative optimal Cu dose response from Cu(HMTBa)2 is 199 mg/kg. The cumulative Cu level was calculated from total Cu intake divided by total feed intake in the 42-d trial. Poly. = polynomial. 
ReSULTS
The effects of level and source of Cu on cumulative performance response (ADG, ADFI, and G:F) are presented on Table 4 and Fig. 1, 2 , and 3. When data from the 2 sources were combined, the cumulative ADG responded to Cu supplementation quadratically (P = 0.050), with predicted peak gain response at Cu level of 174 mg/kg. When the regressions of 2 sources were evaluated separately, ADG tended to quadratically respond to CuSO 4 (P = 0.073), with predicted peak gain response at Cu level of 150 mg/kg; ADG quadratically responded to Cu(HMTBa) 2 (P < 0.05), with predicted peak gain response at Cu level of 199 mg/ kg. However, the regression coefficients of linear and quadratic of ADFI between CuSO 4 and Cu(HMTBa) 2 were not different (P = 0.48 for linear and P = 0.95 for quadratic) from each other.
Similarly, the cumulative ADFI responded quadratically (P < 0.01) with increasing dietary Cu supplementation, with predicted peak intake at Cu level of 119 mg/kg. For each individual source, ADFI responded to CuSO 4 supplementation quadratically (P < 0.01), with predicted peak response at Cu level of 114 mg/ kg. Average feed intake responded to Cu(HMTBa) 2 quadratically (P < 0.01) as well, with predicted peak response at Cu level of 129 mg/kg. Similar to ADG, the regression coefficients of linear and quadratic of ADG between CuSO 4 and Cu(HMTBa) 2 for ADFI were not different (P = 0.17 for linear and P = 0.12 for quadratic) from each other.
The cumulative G:F responded linearly (P < 0.05; quadratic coefficients, P > 0.10) with addition of Cu in the diet when the sources were combined. For the individual source, feed conversion ratio (G:F) responded to CuSO 4 (P = 0.054) as well as Cu(HMTBa) 2 (P < 0.01) supplementation linearly. In addition, the linear regression coefficients of the 2 sources, CuSO 4 and Cu(HMTBa) 2, were significantly different (P < 0.01), indicating the different responses in G:F for CuSO 4 and Cu(HMTBa) 2 . The linear slope for increasing Cu supplementation on G:F was 2.1-fold (0.15 vs. 0.07) higher for Cu(HMTBa) 2 than for CuSO 4 , indicating that Cu(HMTBa) 2 is more effective than CuSO 4 in improving feed efficiency . Table 5 illustrates the ADG, ADFI, and feed conversion ratio for each phase in response to Cu addition. In the combined data from both Cu sources, with increasing Cu supplementation in the diet, ADG from phases I and II responded linearly (P < 0.01) whereas no Cu response regression was fitted in Phase III (P = 0.48 for linear slope). When comparing the response curve from the 2 sources, only in Phase II was the slope of ADG from Cu(HMTBa) 2 significantly different from CuSO 4 (0.18 vs. 0.12; P < 0.05). When linear regression curve was computed in Phase III for both sources, a tendency of source difference was detected (P = 0.074).
In general, with increasing Cu supplementation, ADFI tended to increase linearly (P = 0.086) at Phase I, increased quadratically (P < 0.05) at Phase II, and decreased quadratically (P < 0.05) at Phase III. For each individual Cu source, the response was similar to the combined response and no source difference on daily feed intake was observed. 00078 × x 2 , in which x is the added Cu in milligrams per kilogram and y is the cumulative ADFI in grams per day. The cumulative optimal Cu dose response from combined both source in ADFI is 119 mg/kg, the cumulative optimal Cu dose response from CuSO4 is 114 mg/kg, and the cumulative optimal Cu dose response from Cu(HMTBa)2 is 129 mg/kg. The cumulative Cu level was calculated from total Cu intake divided by total feed intake in the 42-d trial. Poly. = polynomial.
As shown in Table 5 , with increasing Cu level in the diet, feed conversion ratio (G:F) improved linearly (P < 0.01) only at Phase I, with no fitted response at Phase II (P = 0.60 for linear and P = 0.18 for quadratic) and Phase III (P = 0.24 for linear). Interestingly, the response to Cu supplementation differed. For Phase I, both sources improved G:F linearly (P < 0.05 for both sources); for Phase II, Cu(HMTBa) 2 improved G:F linearly (P < 0.05) but not quadratically (P = 0.31) whereas CuSO 4 improved G:F quadratically (P < 0.01) but not linearly (P = 0.25) and, as a result, Cu(HMTBa) 2 and CuSO 4 improved feed efficiency in a distinct fashion (P < 0.01 for linear and quadratic coefficients); for Phase III, no regression curve was fitted for CuSO 4 but there was a linearly tendency for 2 HMTBa = 2-hydroxy-4-(methylthio) butanoic acid.
Cu(HMTBa) 2 (P = 0.074), resulting a different response curve between the 2 sources (P < 0.05 for linear slope).
DISCUSSION
Copper plays an important role in pigs for the synthesis of hemoglobin and for the synthesis and activation of several oxidative enzymes necessary for normal metabolism (Miller et al., 1979) . The NRC (2012) estimated the Cu requirement in 5-to 25-kg nursery pigs to be around 5 to 6 mg/kg. Higher than nutritional levels of Cu (as CuSO 4 ; 125 to 250 mg/kg) improved growth performance in young pigs (Cromwell et al., 1989) . The growth response to Cu in young pigs is independent of, and in addition to, the growth response to other antibacterial agents (Cromwell, 2001) . Pharmacological levels of Zn (2,000 to 6,000 mg/kg) from ZnO have been reported to reduce postweaning scouring and increase weight gain for 14 d after weaning (Poulsen, 1989; Rutkowska-Pejsak et al., 1998; Heo et al., 2010) . In studies with both high dietary level of Zn (3,000 mg/kg, as ZnO) and Cu (250 mg/ kg, as CuSO 4 ), both were individually efficacious at promoting growth but were not additive when they were added in combination to diets for weanling pigs (Smith et al., 1997; Hill et al., 2000) . However, Perez et al. (2011) reported that the combination of high Zn levels and high levels of Cu from available sources were additive. In the current multitrial analyses, all 6 trials were conducted under the same location, with same management, and under the same commercial conditions (22 to 25 pigs per pen) with similar diet ingredients and formulations, which were typical cornsoybean meal complex diets with added fat, 3,000 mg/ kg Zn from ZnO, and inclusion of antibiotics during the early phase. The slight difference in growth performance across trials from the basal diet is probably due to slight differences in weaning weight and energy and nutrient levels as well as seasonal effects. Improved growth response to added Cu was observed in all 6 trials, which confirmed the efficacy of high levels of Cu in the presence of high levels of ZnO and antibiotics.
Based on a recent meta-analysis of Cu (94% observations as CuSO 4 ) dose response on growth performance in 5-to 25-kg pigs, Jongbloed et al. (2011) concluded that supplemented Cu improved daily gain in quadratic fashion, with predicted peak response around 155 mg/kg, which closely agrees with the estimate of 150 mg/kg for CuSO 4 in this multitrial analysis. For feed intake, Jongbloed et al. (2011) showed a quadratic response similar to the current analysis. Regarding feed conversion rate, current data from CuSO 4 showed a tendency for a linear response and the literature showed a numerical improvement for feed conversion ratio. These results, especially from CuSO 4 , confirmed that growth performances of the current 6 trials are similar to other published studies and also validated our statistical models.
The mechanism whereby beneficial effects are observed from higher than nutritional supplementation levels of Cu are unknown (NRC, 2012) . The growthstimulating action of dietary Cu has been attributed to its antimicrobial actions (Fuller et al., 1960) , which was evidenced by some more recent observations. Shurson et al. (1990) observed a positive effect of a high level (283 mg/kg) of Cu in daily growth rate and feed intake in traditionally reared pigs and a negative effect in germ-free pigs. Dunning et al. (1998) stated that streptococci are susceptible to Cu under anaerobic conditions while most lactobacilli and Escherichia coli are insensitive. Hojberg et al. (2005) observed that dietary CuSO 4 inhibited the coliforms and thus potential pathogens as well in digesta of newly weaned pigs. Interestingly, a recent trial done by Arnold (2011) demonstrated that bile from pigs fed 250 mg/kg CuSO 4 and 75 mg/kg Cu(HMTBa) 2 had similar antimicrobial effects and both were greater than 75 mg/kg CuSO 4 and the control diet (8 mg/kg Cu as CuSO 4 ). The above observations indicate potential antimicrobial effects of Cu: 1) Cu has a direct antimicrobial effect in the gut and 2) copper has been absorbed in the gut lumen, stored in the liver, secreted to the bile, and then recycled back to the lumen of gut to perform antimicrobial function. The second theory is also partially supported by Zhou et al. (1994b) , whose research demonstrated that intravenous injection of copper histidinate, which bypasses the gut lumen, had growth promoting effects similar to dietary supplementation.
Furthermore, contribution to gut health improvement might be in addition to the antibacterial effect of Cu. Zhao et al. (2007) observed that high Cu (200 mg/kg as proteinates) supplementation in weanling pig increased villus height and reduced crypt depth, thus improving the villus to crypt ratio at the duodenum and jejunum and thus improving gut health. In the current trial, the response of ADG to Cu addition diminished with age. In Phase I, Cu supplementation resulted in 17.2% improvement; in Phase II, the response of ADG to Cu addition resulted in 11.6% improvement; and in Phase III, the improvement of ADG for CuSO 4 was minimal. The weaning transition phase in pigs is commonly accompanied by adverse changes in intestinal morphology, including reduced villus height, increased villus width, increased crypt depth, and reduced absorptive capacity and brush border enzyme activity as well as bacterial infection (i.e., dysbacteriosis), which limits the growth of weaning pigs (McCracken et al., 1999) . The greatest response to Cu addition occurred in Phase I, with diminishing but still effective response in Phase II and no response at Phase III. Therefore, one can speculate that Cu acts as antibacterial agent but also changes the gut morphology to improve gut health.
Another potential mechanism for the growthpromoting effect of Cu is to stimulate feed intake. Literature indicated that high levels of Cu improved feed intake (Cromwell et al., 2001 ) and Zhu et al. (2011) suggested that Cu affected mRNA expression levels of appetite-regulating genes in the hypothalamus. In the current trial described herein, improvements in feed intake were observed in phases I and II whereas minimal improvement was observed in Phase III. A similar pattern was observed for ADG, indicating the growth improvement may have resulted from the improvement in feed intake. However, with an improved G:F for both phases I and II, it is inferred that improved feed intake was not the only mechanism involved in the response to Cu. In fact, a pair-feeding trial shown by Zhou et al. (1994a) indicated high Cu stimulated growth beyond merely increasing feed intake. Furthermore, Yang et al. (2011) demonstrated that high Cu can enhance growth hormone-releasing hormone and suppress somatostatin mRNA expression in hypothalamic of growing pigs. Bowland et al. (1961) and Cromwell et al. (1989) demonstrated a correlation between the bioavailability of Cu source and its growth-promoting action. Zhou et al. (1994b) reported that both BW gain and serum mitogenic activity were stimulated in young pigs given intravenous injections of Cu histidinate every other day for 18 d. Because the gastrointestinal tract was bypassed in this study, these results suggest that Cu can act systemically to promote growth. In the current trial, different response curves from the 2 Cu sources were observed, suggesting different mechanisms of action potentially due to differences in bioavailability between Cu(HMTBa) 2 and CuSO 4 . The literature suggests inconsistent bioavailability among organic sources and varies across studies (Wedekind et al., 1992; Baker and Ammerman, 1995; Ao and Pierce, 2013) . Some studies have suggested no advantage of organic trace minerals over inorganic sources (Bikker et al., 2012; Schlegel et al., 2013) . However, Richards et al. (2010) reported a higher bioavailability of metal from HMTBa chelated sources in the presence of antagonisms regarding tissue deposition and gene expression compared with sulfate sources. Arnold (2011) reported a similar bile antimicrobial effect from 250 mg/ kg CuSO 4 and 75 mg/kg Cu(HMTBa) 2 and both were greater than 75 mg/kg CuSO 4 and the control (8 mg/ kg CuSO 4 ), indicating greater absorption and availability from Cu(HMTBa) 2 compared with CuSO 4 . Liu et al. (2013) reported a greater apparent digestibility of Cu from Cu(HMTBa) 2 compared with CuSO 4 in corn-soybean meal diets but not in semipurified diets. Zhao et al. (2014) reported that Cu(HMTBa) 2 is more effective compared with CuSO 4 as growth promoter in stimulating gain and feed efficiency in both nursery and finisher pigs. These results suggest that bioavailability of different sources largely depends on the diet conditions (i.e., presence of antagonisms such as Ca, P, phytate, and fiber and excesses of other divalent cations) and the measurements used to assess bioavailability value (i.e., life stage, growth performance, gene expression, and tissue content).
In conclusion, this multitrial analysis confirmed that added Cu improved growth performance in nursery pigs in addition to the presence of pharmacological levels of Zn as ZnO and antibacterial agents. A greater response to added Cu was observed in phases I and II compared to Phase III. The different response curves of Cu from Cu(HMTBa) 2 and CuSO 4 demonstrated that Cu(HMTBa) 2 is more effective than CuSO 4 in improving feed efficiency, especially in phases II and III.
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